Relief Therapeutics Appoints Christopher Wick as Senior Director, Head of U.S. Sales
Proven Pharmaceutical Sales Professional Brings Big Pharma Experience to Relief's U.S. Expansion ActivitiesGENEVA, SWITZERLAND / ACCESSWIRE / March 21, 2022...
News
Relief Therapeutics Files Amendment No. 1 to its Registration Statement on Form 20-F with the U.S. Securities and Exchange Commission
GENEVA, SWITZERLAND / ACCESSWIRE / March 21, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) ("Relief"), announced today that it has...
Moderna Announces New Supply Agreement for 2023 with Switzerland for Additional Seven Million Doses of Moderna’s COVID-19 Booster Vaccine
CAMBRIDGE, MA / ACCESSWIRE / March 21, 2022 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics...
Athira Pharma Presents Study Overview and Baseline Data from ACT-AD Phase 2 Trial of Fosgonimeton in Mild-to-Moderate Alzheimer’s Disease at the 2022 AD/PD™ Congress
BOTHELL, Wash., March 20, 2022 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on...
Core One Labs to Investigate Soliciting Investment and Potential Takeover Opportunities
VANCOUVER, British Columbia, March 19, 2022 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN:...
Advanced Proteome Therapeutics Announces Warrant Extension
Vancouver, British Columbia--(Newsfile Corp. - March 18, 2022) - Advanced Proteome Therapeutics Corporation (TSXV: APC) (FSE: 0E81) ("APC" or the "Company") announces that,...
Cloud DX Announces Closing of Private Placement
KITCHENER, ON / ACCESSWIRE / March 18, 2022 / Cloud DX (TSXV:CDX)(OTCQB:CDXFF), a leading North American provider of virtual care...
All of Us Research Program Releases Genomic Data to Researchers, Combined with Participant-Generated Data Collected on Vibrent Health’s Digital Health Research Platform
Precision medicine initiative leverages innovative technologies and unprecedented 80% diverse participant base to drive new research aiming to support novel...
Melzi Surgical to Present at the LSI USA ’22 Emerging Medtech Summit
Presentation on Friday, March 18th at 2:00 PM PTRENO, NV / ACCESSWIRE / March 18, 2022 / Melzi Surgical ("Melzi"...
Welcome to IRLAB’s Capital Markets Day 2022
GOTHENBURG, SWEDEN / ACCESSWIRE / March 18, 2022 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA)IRLAB (Nasdaq Stockholm: IRLAB A) will host a capital...
Shineco, Inc. Plans to Introduce a Private Equity Fund to Help its Business Transition
BEIJING, March 18, 2022 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer and distributor of...
Optimi Health Begins Cultivation Of Natural Psilocybin For Use In Clinical Trials
VANCOUVER, British Columbia, March 18, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or...
Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc., Announces Final Results for SP-102 (SEMDEXA™) Efficacy and Safety from its Pivotal Phase 3 Clinical Trial Program for Sciatica Pain Management Supporting the Potential for First to Market Opportunity
SP-102 (SEMDEXA™), with 401 patients enrolled in the C.L.E.A.R. trial (Corticosteroid Lumbosacral Epidural Analgesia in Radiculopathy), experienced a rapid onset...
Nymox Announces $5 Million Registered Direct Offering
IRVINE, Calif., March 18, 2022 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) today announced it has entered into definitive...
Palisade Bio (Nasdaq: PALI) Reports Year End 2021 Financial Results and Corporate Update
CARLSBAD, Calif., March 18, 2022 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a clinical stage biopharmaceutical...
MiNK Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
AgenT-797 (Allo-iNKTs) +/- anti-PD-1 clinical trial underway in solid tumor cancersBenefit in severe COVID-19 ARDS shows 75% survival rate in...
Align Technology Launches New Invisalign System Innovations for Orthodontic and Restorative Dental Treatment Planning with Integration of CBCT into ClinCheck Treatment Planning Software
Digitally integrating Cone Beam Computed Tomography (CBCT) scan and intraoral scan data into ClinCheck treatment plans enables doctors to confidently...
Dentsply Sirona to Participate in the Piper Sandler Virtual Dental Day
CHARLOTTE, N.C., March 18, 2022 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY) today announced that the Company...
Reviva Pharmaceuticals Holdings, Inc. to Present at Upcoming Virtual Investor Conferences
- 5th Annual Neuroscience Innovation Forum - - BIO-Europe Spring® 2022 - CUPERTINO, Calif., March 18, 2022 (GLOBE NEWSWIRE) --...
HTG Molecular Diagnostics Announces $7.5 Million Private Placement
TUCSON, Ariz., March 18, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose...